Glaxosmithkline Share News (GSK)

London pre-open: Stocks seen lower on profit-taking

(ShareCast News) - London stocks are expected to open a little weaker on Monday as investors look to book some profits following recent gains. The FTSE 100 is seen starting 29 points lower than Friday's close at 6,170. Michael Hewson, chief market analyst at CMC Markets, said: "Despite this recover

GlaxoSmithKline: Low Rate Of Organ Damage Progression For Benlysta

Swiss Basilea says profits still 2-3 years away

* CFO expects profitability in 2-3 years * Basilea hopes new anti-infection drugs mitigate setbacks * GSK dumped U.S. approval bid for Basilea skin drug in January By John Miller and Paul Arnold ZURICH, Feb 29 (Reuters) - Swiss drugmaker Basilea expects to move into profi

GlaxoSmithKline starts hunt for successor to CEO Witty

* Drugmaker's chairman sees succession planning as priority * New CEO not expected to take over before 2017 By Ben Hirschler LONDON, Feb 29 (Reuters) - GlaxoSmithKline's chairman is starting the process of seeking a new chief executive to succeed Andrew Witty, although a handov

PRESS: GlaxoSmithKline To Ramp Up Search For New CEO - FT

Sunday newspaper round-up: Pound, GSK, Sainsbury's, HSBC

(ShareCast News) - Sterling will fall to $1.28 by the end of 2016, its lowest level against the US dollar in three decades, currency strategists have cautioned. If Britain votes to leave the European Union the fall will be even worse, the Sunday Telegraph reported that Deutsche Bank analysts saw a f

GlaxoSmithKline's ViiV Presents Positive Results For Cabotegravir

Brexit is the wrong prescription, says European pharma industry

* Threat to regulatory system and research collaboration * UK exit seen harming British and European pharma sector By Ben Hirschler LONDON, Feb 24 (Reuters) - Britain's departure from the European Union would threaten scientific research and jeopardise the 28-nation bloc's syste

Business Leaders Warn Brexit Would "Deter Investment, Threaten Jobs"

Merck KGaA says consumer health saw 'nice' growth in 2015

By Ludwig Burger and Patricia Weiss DARMSTADT, Germany, Feb 23 (Reuters) - German drugs and chemicals group Merck KGaA has seen solid growth at its consumer healthcare business last year, underpinning the family-owned company's commitment to holding on to the business. The division, a

Monday broker round-up

(ShareCast News) - Coca-Cola Hbc: JP Morgan reiterates neutral with a target price of 1450p, Nomura stays at buy with a 1330p target and Deutsche Bank keeps at hold with a target price of 1500p. Standard Life: JP Morgan keeps at overweight with a target of 465p and Deutsche Bank reiterates buy, 415p

BROKER RATINGS SUMMARY: JPMorgan Upgrades Essentra To Overweight

Sunday newspaper round-up: GSK, Sainsbury's, BT, Imagination Technologies

(ShareCast News) - Financial institutions in the City of London are fairly pleased with David Cameron's agreement with the European Union ahead of June's referendum as it looks to have secured the Square Mile from excessive further Brussels red tape. A potentially painful sticking point has been avo

BROKER RATINGS SUMMARY: Macquarie Starts Burberry At Outperform

LONDON BRIEFING: Coca-Cola HBC And Standard Life Impress With Results